Write in a clean editor, then format for The Lancet Microbe in one click — DocuGuru applies the official Clinical & Medical Journals template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
The Lancet Microbe is a peer-reviewed journal published by Clinical & Medical Journals, covering SARS-CoV-2 and COVID-19 Research, Antibiotic Resistance in Bacteria, Antibiotic Use and Resistance. Over its lifetime it has published 1,409 papers, which have received 41,516 citations.
| Publisher | Clinical & Medical Journals |
|---|---|
| Reference style | Numbered (Vancouver) Numbered — [1], [2] in the text 1. Smith A, Jones B, Lee C. A representative article title. The Lancet Microbe. 2023;12(3):45–58.
Formats any DOI in The Lancet Microbe style. No sign-up. |
| Publishes research in | SARS-CoV-2 and COVID-19 Research Antibiotic Resistance in Bacteria Antibiotic Use and Resistance Tuberculosis Research and Epidemiology COVID-19 Clinical Research Studies |
| ISSN | 2666-5247 |
| Citation impact (2-yr) | 11.11 |
| h-index | 90 |
| i10-index | 616 |
| Article processing charge | $5,000 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | University of Oxford |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
We previously reported the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in different clinical samples.1Pan Y Zhang D Yang P Poon LLM Wang Q Viral load of SARS-CoV-2 in clinical samples.Lancet Infect Dis. 2020; (published online Feb 24.)https://doi.org/10.1016/S1473-3099(20)30113-4Summary Full Text Full Text PDF Scopus (1192) Google Scholar This virus can be detected on…
On Oct 27, WHO released its Global Tuberculosis Report 2022. The document provides an extensive assessment of the global tuberculosis burden, based on data reported from 202 countries and territories, including over 99% of the global population and of tuberculosis cases.
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported from China in January, 2020. SARS-CoV-2 is efficiently transmitted from person to person and, in 2 months, has caused more than 82 000 laboratory-confirmed cases of coronavirus disease 2019 (COVID-19) and 2800 deaths in 46 countries. The total number of cases and deaths has surpassed…
BACKGROUND: Severe COVID-19 has a high mortality rate. Comprehensive pathological descriptions of COVID-19 are scarce and limited in scope. We aimed to describe the histopathological findings and viral tropism in patients who died of severe COVID-19. METHODS: In this case series, patients were considered eligible if they were older than 18 years, with premortem diagnosis…
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) targets multiple organs and causes severe coagulopathy. Histopathological organ changes might not only be attributable to a direct virus-induced effect, but also the immune response. The aims of this study were to assess the duration of viral presence, identify the extent of inflammatory response, and investigate the…
